Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#71 / 100 Total
VRSN - Verisign Inc. - Stock Price Chart
TickerVRSN [NASD, S&P 500]
CompanyVerisign Inc.
CountryUSA
IndustrySoftware - Infrastructure
Market Cap17.19BEPS (ttm)8.13
P/E21.22EPS this Y-0.04%
Forward P/E19.96EPS next Y9.49%
PEG2.65EPS past 5Y10.71%
P/S11.36EPS next 5Y8.00%
P/B-EPS Q/Q13.03%
Dividend-Sales Q/Q5.46%
Insider Own0.89%Inst Own93.50%
Insider Trans-7.30%Inst Trans-2.24%
Short Float1.76%EarningsApr 25/a
Analyst Recom2.60Target Price204.33
Avg Volume696.53K52W Range167.04 - 229.72
VeriSign, Inc. provides domain name registry services and Internet infrastructure, which enables Internet navigation for many of the world's most recognized domain names. It enables the security, stability, and resiliency of key Internet infrastructure and services, including providing root zone maintainer services. The company was founded by D. James Bidzos in 1995, and is headquartered in Reston, VA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McPherson Danny REVP - Engineering & CSOMay 17 '24Sale170.141,200204,16829,181May 20 04:37 PM
Buchalter Yehuda AriDirectorMay 10 '24Sale170.01734124,7912,927May 13 04:40 PM
Buchalter Yehuda AriDirectorMay 09 '24Sale170.01866147,2323,661May 13 04:40 PM
Buchalter Yehuda AriDirectorMay 07 '24Sale170.0011704,527May 09 04:43 PM
Indelicarto Thomas CEVP, Gen Counsel & SecretaryApr 11 '24Sale190.00614116,66041,955Apr 12 04:32 PM
TCMD - Tactile Systems Technology Inc - Stock Price Chart
TickerTCMD [NASD, RUT]
CompanyTactile Systems Technology Inc
CountryUSA
IndustryMedical Devices
Market Cap324.32MEPS (ttm)1.18
P/E11.54EPS this Y-55.03%
Forward P/E15.47EPS next Y54.15%
PEG2.31EPS past 5Y29.16%
P/S1.17EPS next 5Y5.00%
P/B1.68EPS Q/Q-5.30%
Dividend-Sales Q/Q3.81%
Insider Own2.91%Inst Own89.61%
Insider Trans-4.11%Inst Trans-1.74%
Short Float5.79%EarningsMay 06/a
Analyst Recom1.00Target Price20.67
Avg Volume297.98K52W Range9.69 - 26.11
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Birkemeyer Elaine M.Chief Financial OfficerMay 16 '24Sale13.683,04141,59061,295May 20 04:36 PM
BURKE WILLIAM WDirectorMay 08 '24Sale14.062,50035,15025,273May 10 04:24 PM
Burns KristieSr. VP Mktg & Clinical AffairsMay 06 '24Sale14.3781511,71362,574May 08 05:23 PM
REUVERS DANIEL L.President and CEOFeb 29 '24Sale15.251,39621,289238,027Feb 29 08:42 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 29 '24Sale15.252433,70663,389Feb 29 08:43 PM
RCKT - Rocket Pharmaceuticals Inc - Stock Price Chart
TickerRCKT [NASD, RUT]
CompanyRocket Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.07BEPS (ttm)-2.87
P/E-EPS this Y10.56%
Forward P/E-EPS next Y24.45%
PEG-EPS past 5Y-9.09%
P/S-EPS next 5Y41.70%
P/B4.69EPS Q/Q9.66%
Dividend-Sales Q/Q-
Insider Own7.21%Inst Own99.64%
Insider Trans-6.23%Inst Trans5.52%
Short Float11.68%EarningsMay 06/a
Analyst Recom1.14Target Price49.08
Avg Volume696.46K52W Range14.89 - 32.53
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shah GauravCEOMay 16 '24Sale23.359,790228,596728,069May 20 04:33 PM
Patel KinnariSee RemarksMay 16 '24Sale23.354,04694,474400,972May 20 04:26 PM
Militello JohnSee RemarksMay 16 '24Sale23.351,07925,19553,327May 20 04:36 PM
Wilson MartinGeneral CounselMay 16 '24Sale23.351,04824,47165,762May 20 04:29 PM
Patel KinnariSee RemarksMay 14 '24Option Exercise0.009,5430301,824May 20 04:26 PM
LMAT - Lemaitre Vascular Inc - Stock Price Chart
TickerLMAT [NASD, RUT]
CompanyLemaitre Vascular Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap1.78BEPS (ttm)1.51
P/E52.60EPS this Y32.28%
Forward P/E40.84EPS next Y9.66%
PEG8.77EPS past 5Y3.45%
P/S8.92EPS next 5Y6.00%
P/B5.78EPS Q/Q61.54%
Dividend0.81%Sales Q/Q13.60%
Insider Own9.77%Inst Own90.72%
Insider Trans-16.69%Inst Trans-1.43%
Short Float4.32%EarningsMay 02/a
Analyst Recom1.50Target Price78.57
Avg Volume138.66K52W Range44.27 - 79.19
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ross Bridget ADirectorMay 16 '24Option Exercise30.005,500165,0007,778May 20 04:35 PM
Ross Bridget ADirectorMay 16 '24Sale77.995,500428,9452,278May 20 04:35 PM
LeMaitre George WChairman and CEOMay 14 '24Sale76.8040,9683,146,3711,998,334May 15 04:11 PM
LeMaitre George WChairman and CEOMay 13 '24Sale76.4235,8262,737,6872,043,302May 15 04:11 PM
LeMaitre George WChairman and CEOMay 08 '24Sale75.308,000602,4272,079,128May 08 04:51 PM
THRD - Third Harmonic Bio Inc - Stock Price Chart
TickerTHRD [NASD, RUT]
CompanyThird Harmonic Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap589.68MEPS (ttm)-0.74
P/E-EPS this Y-64.66%
Forward P/E-EPS next Y-31.81%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.20EPS Q/Q50.98%
Dividend-Sales Q/Q-
Insider Own63.11%Inst Own39.80%
Insider Trans-0.29%Inst Trans-
Short Float13.58%EarningsMay 15/b
Analyst Recom2.00Target Price13.50
Avg Volume150.41K52W Range4.40 - 14.58
Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dittman JenniferChief Development Oper OfficerMay 16 '24Sale14.0423,578331,0660May 20 04:33 PM
Holles Natalie C.CEOMay 09 '24Option Exercise4.2020,22284,9321,239,058May 10 04:04 PM
Holles Natalie C.CEOMay 09 '24Sale12.1820,222246,3001,218,836May 10 04:04 PM
Holles Natalie C.CEOApr 11 '24Option Exercise4.2013,55856,9441,232,394Apr 15 04:14 PM
Holles Natalie C.CEOApr 11 '24Sale12.1913,558165,2141,218,836Apr 15 04:14 PM
DUOL - Duolingo Inc - Stock Price Chart
TickerDUOL [NASD, RUT]
CompanyDuolingo Inc
CountryUSA
IndustrySoftware - Application
Market Cap7.66BEPS (ttm)0.96
P/E185.76EPS this Y340.83%
Forward P/E72.48EPS next Y58.76%
PEG5.42EPS past 5Y-
P/S13.14EPS next 5Y34.30%
P/B10.75EPS Q/Q995.13%
Dividend-Sales Q/Q44.87%
Insider Own15.45%Inst Own80.14%
Insider Trans-4.62%Inst Trans-0.10%
Short Float8.42%EarningsMay 08/a
Analyst Recom2.12Target Price252.65
Avg Volume911.77K52W Range121.89 - 251.30
Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Skaruppa MatthewChief Financial OfficerMay 17 '24Sale177.292,698478,33286,709May 20 04:32 PM
Glance NatalieChief Engineering OfficerMay 06 '24Sale247.821,500371,735123,005May 07 04:19 PM
Skaruppa MatthewChief Financial OfficerMay 01 '24Option Exercise14.428,000115,36072,523May 03 07:38 PM
von Ahn LuisPresident & CEO, Co-FounderMay 01 '24Sale223.5112,0002,682,1390May 03 07:37 PM
Hacker SeverinChief Tech Officer, Co-FounderMay 01 '24Sale223.4710,0002,234,6530May 03 07:39 PM
STE - Steris Plc - Stock Price Chart
TickerSTE [NYSE, S&P 500]
CompanySteris Plc
CountryIreland
IndustryMedical Devices
Market Cap23.00BEPS (ttm)3.81
P/E61.13EPS this Y4.21%
Forward P/E23.13EPS next Y9.37%
PEG6.11EPS past 5Y1.36%
P/S4.23EPS next 5Y10.00%
P/B3.58EPS Q/Q-100.74%
Dividend0.96%Sales Q/Q2.49%
Insider Own0.32%Inst Own97.91%
Insider Trans-12.89%Inst Trans0.33%
Short Float2.41%EarningsMay 08/a
Analyst Recom2.00Target Price243.00
Avg Volume510.94K52W Range195.47 - 254.00
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tamaro RenatoV.P. & Corporate TreasurerMay 16 '24Option Exercise114.221,154131,8107,831May 20 04:31 PM
Tamaro RenatoV.P. & Corporate TreasurerMay 16 '24Sale231.641,154267,3136,677May 20 04:31 PM
TOKICH MICHAEL JSr. Vice Pres., CFOMay 15 '24Option Exercise77.0732,0002,466,24074,464May 17 04:31 PM
FELDMANN CYNTHIA LDirectorMay 15 '24Option Exercise86.232,000172,4602,705May 17 04:33 PM
TOKICH MICHAEL JSr. Vice Pres., CFOMay 15 '24Sale235.3932,0007,532,36642,464May 17 04:31 PM
CRM - Salesforce Inc - Stock Price Chart
TickerCRM [NYSE, DJIA, S&P 500]
CompanySalesforce Inc
CountryUSA
IndustrySoftware - Application
Market Cap278.54BEPS (ttm)4.21
P/E68.27EPS this Y19.16%
Forward P/E25.93EPS next Y13.04%
PEG4.21EPS past 5Y24.06%
P/S7.99EPS next 5Y16.22%
P/B4.67EPS Q/Q1576.91%
Dividend0.12%Sales Q/Q10.77%
Insider Own3.06%Inst Own82.47%
Insider Trans-10.16%Inst Trans-0.97%
Short Float0.88%EarningsMay 29/a
Analyst Recom1.66Target Price336.93
Avg Volume5.58M52W Range193.68 - 318.71
Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Benioff MarcChair and CEOMay 17 '24Sale286.2015,0004,292,95312,527,327May 20 04:31 PM
Benioff MarcChair and CEOMay 16 '24Sale286.4415,0004,296,58812,542,327May 17 04:21 PM
Millham BrianPresident and COOMay 15 '24Option Exercise218.212,106459,5502,106May 16 04:53 PM
Benioff MarcChair and CEOMay 15 '24Sale284.7315,0004,270,88112,557,327May 16 04:45 PM
Millham BrianPresident and COOMay 15 '24Sale280.002,106589,6800May 16 04:53 PM
UTHR - United Therapeutics Corp - Stock Price Chart
TickerUTHR [NASD]
CompanyUnited Therapeutics Corp
CountryUSA
IndustryBiotechnology
Market Cap12.19BEPS (ttm)21.15
P/E12.99EPS this Y24.97%
Forward P/E10.20EPS next Y8.75%
PEG1.34EPS past 5Y8.15%
P/S4.88EPS next 5Y9.70%
P/B2.27EPS Q/Q27.02%
Dividend-Sales Q/Q33.70%
Insider Own7.84%Inst Own102.43%
Insider Trans-13.92%Inst Trans1.04%
Short Float9.34%EarningsMay 01/b
Analyst Recom1.59Target Price298.16
Avg Volume532.89K52W Range204.44 - 275.00
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROTHBLATT MARTINE ADirectorMay 17 '24Option Exercise129.493,600466,1643,730May 20 04:30 PM
ROTHBLATT MARTINE ADirectorMay 17 '24Sale273.273,600983,765130May 20 04:30 PM
ROTHBLATT MARTINE ADirectorMay 16 '24Option Exercise129.493,600466,1643,730May 20 04:30 PM
ROTHBLATT MARTINE ADirectorMay 16 '24Sale272.373,600980,534130May 20 04:30 PM
EDGEMOND JAMESCFO AND TREASURERMay 15 '24Option Exercise163.3040,1606,558,12826,578May 16 04:30 PM
MTSI - MACOM Technology Solutions Holdings Inc - Stock Price Chart
TickerMTSI [NASD, RUT]
CompanyMACOM Technology Solutions Holdings Inc
CountryUSA
IndustrySemiconductors
Market Cap7.38BEPS (ttm)0.88
P/E115.80EPS this Y-5.53%
Forward P/E31.23EPS next Y28.53%
PEG7.72EPS past 5Y-
P/S11.58EPS next 5Y15.00%
P/B7.06EPS Q/Q-43.33%
Dividend-Sales Q/Q6.98%
Insider Own21.03%Inst Own84.27%
Insider Trans-11.47%Inst Trans4.81%
Short Float7.75%EarningsMay 02/b
Analyst Recom1.79Target Price111.92
Avg Volume543.51K52W Range56.60 - 107.00
MACOM Technology Solutions Holdings, Inc. engages in designing, developing, manufacturing, and marketing semiconductors and modules. The firm is involved in the provision of products for telecommunications (Telecom), industrial and defense (I&D), and data center industries. The company was founded on March 25, 2009 and is headquartered in Lowell, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OCAMPO SUSANDirectorMay 16 '24Sale102.9882,3618,481,6497,489,804May 17 04:43 PM
BLAND CHARLES RDirectorMay 16 '24Sale102.392,500255,96626,439May 20 04:29 PM
OCAMPO SUSANDirectorMay 15 '24Sale102.82150,00015,422,8477,572,165May 17 04:43 PM
OCAMPO SUSANDirectorMay 14 '24Sale103.0485,8748,848,4577,722,165May 15 04:16 PM
OCAMPO SUSANDirectorMay 13 '24Sale103.2161,7656,374,7667,808,039May 15 04:16 PM
12345678910